Allogene Therapeutics
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Allogene Therapeutics's balance sheet done over the years? Its assets were worth $642,837,000 last year, which is less than in the previous period. 20% of Allogene Therapeutics’s total assets is currently financed by debt. Its liabilities reached the amount of $130,604,000, which means an decrease by -14% compared compared to last year.
Debt to Assets
| 2017 | 0 | 2K | Infinity% |
|---|---|---|---|
| 2018 | 773855000 | 70.69M | 9.13% |
| 2019 | 717802000 | 88.77M | 12.37% |
| 2020 | 1227829000 | 148.21M | 12.07% |
| 2021 | 1038634000 | 122.22M | 11.77% |
| 2022 | 817079000 | 151.20M | 18.51% |
| 2023 | 642837000 | 130.60M | 20.32% |
ALLO Balance Sheet (2017 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
Assets | |||||||
Current assets: | |||||||
Cash and cash equivalents | 83.15M | 576.47M | 809.48M | 1.03B | 588.85M | 721.35M | 0 |
Short term investments | 365.54M | 455.41M | 283.98M | 644.55M | 355.40M | 366.95M | 0 |
Net receivables | 0 | 3.3M | 6M | 2.8M | 2.40M | 3.10M | 0 |
Inventory | 0 | -62.45M | -20.02M | -207.00M | -60.72M | -261.96M | 0 |
Other current assets | 10.41M | 11.50M | 14.02M | 17.22M | 14.04M | 5.49M | 0 |
Total current assets | 459.11M | 528.82M | 809.48M | 845.13M | 544.57M | 467.98M | 0 |
Non-current assets: | |||||||
Property, Plant and Equipment | 163.18M | 196.43M | 181.02M | 160.13M | 100.94M | 41.61M | 0 |
Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible assets | 0 | 0 | 0 | 0 | 151K | 754K | 0 |
Long term investments | 3.64M | 59.15M | 370.18M | 207.94M | 63.21M | 261.96M | 0 |
Other non-current assets | 16.89M | 32.67M | -322.05M | 14.61M | 8.91M | 1.54M | 0 |
Total non-current assets | 183.72M | 288.25M | 229.15M | 382.69M | 173.22M | 305.87M | 0 |
Total assets | 642.83M | 817.07M | 1.03B | 1.22B | 717.80M | 773.85M | 0 |
Liabilities | |||||||
| Current liabilities: | |||||||
Accounts payable | |||||||
Deferred revenue | 86K | 885K | 423K | 38.99M | 0 | 0 | 0 |
Short term debt | 6.77M | 6.00M | 3.2M | 2.97M | 0 | 0 | 0 |
Total current liabilities | 37.07M | 54.51M | 48.17M | 94.32M | 33.07M | 29.45M | 2K |
| Non-current liabilities: | |||||||
Long term debt | 88.34M | 95.12M | 69.92M | 50.80M | 51.34M | 34.45M | 0 |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 5.17M | 1.56M | 4.12M | 3.08M | 4.35M | 6.77M | 0 |
Total non-current liabilities | 93.52M | 96.69M | 74.05M | 53.89M | 55.7M | 41.23M | 0 |
Total liabilities | 130.60M | 151.20M | 122.22M | 148.21M | 88.77M | 70.69M | 2K |
| Data source | Data source | Data source | Data source | Data source | Data source |